Loading company…
Riskpilot
← Back to search
Sign in
Get full access
PRO OCULUS AS
AS
Active
Org 924412240
Svalbardveien 4, 0375 Oslo
Medical specialists activities · NACE 8622
Est. 2020
6 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 9,2M
+12% vs 2023
EBITDA margin
14.0%
+1263% vs 2023
Equity ratio
75.7%
Financial strength
Net profit 2024
NOK 1M
+27218% vs 2023
EBITDA — year on year
NOK millions
0M
1M
1M
2M
3M
2M
2020
1M
-50%
2021
1M
0%
2022
0M
-100%
2023
1M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 9,2M
+12%
EBITDA
NOK 1,3M
+1263%
Net profit
NOK 1M
+27218%
Total assets
NOK 4,1M
+31%
Equity
NOK 3,1M
+49%
Employees
6
—
Company information
Legal name
PRO OCULUS AS
Org number
924412240
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
15. januar 2020
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Øyelege og hertil knyttet virksomhet.
Contact
Address
Svalbardveien 4, 0375 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
3M
5M
8M
10M
6M
2020
7M
2021
8M
2022
8M
2023
9M
2024
EBITDA
NOK millions
0M
1M
1M
2M
2M
2M
2020
1M
2021
1M
2022
0M
2023
1M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
5 780
6 662
8 403
8 213
9 232
Staff expenses
−947
−1 648
−2 325
−2 880
−3 135
EBITDA
1 776
573
520
95
1 293
Depreciation & amort.
−53
−89
−89
−90
−110
EBIT
1 723
484
432
5
1 183
Net financials
0
0
1
1
129
Profit before tax
1 723
484
432
6
1 312
Tax
379
106
95
9
291
Net profit
1 344
377
337
−4
1 021
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 210
2 485
2 893
3 123
4 105
Equity
1 374
1 751
2 088
2 084
3 106
Long-term debt
0
0
0
1
1
Short-term debt
836
734
805
1 037
998
Total debt
836
734
805
1 039
999
Financial ratios
5-year trend
EBITDA margin
14.0%
This company
15.8%
Market median
-11% vs market
2020
2024
Equity ratio
75.7%
This company
38.2%
Market median
+98% vs market
2020
2024
Return on equity
32.9%
This company
18.4%
Market median
+79% vs market
2020
2024
Net profit margin
11.1%
This company
8.1%
Market median
+37% vs market
2020
2024
Asset turnover
2.25×
This company
1.12×
Market median
+101% vs market
2020
2024
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-15 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
JB
Jørn Beckrøge
Chief Executive Officer
Chief Executive Officer
2020
—
—
HE
Helena Enger
Deputy Member
Deputy Member
2020
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Gynoculus As
Company
100.0%
100.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Gynoculus As
PRO OCULUS AS
(this company)
Board network connections
Board members of PRO OCULUS AS also hold positions in
0
other companies.
Person
Role here
Other companies
Jørn Beckrøge
Chief Executive Officer
0 companies
Helena Enger
Deputy Member
0 companies